How long does it take to stop taking selumetinib?

Selumetinib is the first MEK inhibitor available outside of clinical trials for the treatment of plexiform neurofibromas (PNs), which only a small number of patients with neurofibromatosis type 1 (NF1) have symptomatic plexiform neurofibromas. Treatment with selumetinib is the only available medical treatment for NF1 patients because of its extensive inoperable PNs that cause significant pain, functional disability, and/or disfigurement.

Results from clinical studies using selumetinib in pediatric patients indicate that approximately 80% of patients will respond to treatment. Most NF1 patients with PNs are asymptomatic, and the benefit of treating these patients has not been established. Typically, the length of discontinuation depends on the patient's condition and response to treatment. Some patients may require long-term use of selumetinib to control disease progression, while others may be able to discontinue the drug after a period of time. This decision should be made by a physician, who will assess the patient's situation and provide appropriate advice.

SelumetinibThe original drug has been launched in China, but it has not yet entered the scope of medical insurance. SpecificationThe price of 10mg*60 tablets per box may be more than 20,000 yuan, which is relatively expensive. SelumetinibOriginal drug marketed overseas, the price of 10mg*60 pills per box may be more than 50,000 yuan, and the price of 25mg*60 pills per box may be 1 More than RMB 00,000 (the price may fluctuate due to the exchange rate). The ingredients of the original version of selumetinib sold at home and abroad are basically the same. There is currently no generic version of selumetinib on the market. For more drug information and specific prices, please consult Yaode Medical Consultants.